Stalfort John A III

Director at Acumen Pharmaceuticals, Inc. · on record since Jun 5, 2026
Director at Taysha Gene Therapies, Inc. · on record since Jun 2, 2026
Director at Dova Pharmaceuticals Inc. · on record since Jun 28, 2017
Director at Verrica Pharmaceuticals Inc. · on record since Jun 19, 2018

Insider trading activity of Stalfort John A III

Transactions on record: 36; since Jun 19, 2018

Open-market buys: 10; $2.3M

Open-market sells: 0

Companies traded: 4; last filing Jun 5, 2026

Figures computed from official regulatory filings — .

Companies where Stalfort John A III has traded

Acumen Pharmaceuticals, Inc.13 tx · $560K · Jun 5, 2026
Taysha Gene Therapies, Inc.10 tx · $700K · Jun 2, 2026
Verrica Pharmaceuticals Inc.11 tx · $796.8K · Nov 26, 2024
Dova Pharmaceuticals Inc.2 tx · $17.7M · Nov 12, 2019

Track record of Stalfort John A III

Statistical track record

Free account

Open-market buys: 12

Last buy: Nov 22, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Stalfort John A III

Co-insiders of Stalfort John A III

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2026	AwardD (derivative)	53,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2026	Award	35,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 2, 2026	AwardD (derivative)	42,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 2, 2026	Award	21,335	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2025	Award	12,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2025	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 4, 2025	Award	56,623	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	113,246	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	Gift	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	BuyD (derivative)	561,797	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	BuyD (derivative)	561,797	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	Buy	1,123,595	—	n/a (No price was disclosed in the filing)	conv 90ClusterFirst in 12mo	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 31, 2024	Award	49,220	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 31, 2024	AwardD (derivative)	98,440	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	388,889	0.90 USD	$350K	conv 57ClusterFirst in 12mo	SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	388,889	0.90 USD	$350K	conv 60ClusterFirst in 12mo	SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Gift	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 26, 2023	AwardD (derivative)	43,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 7, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Jul 5, 2022	Buy	238,095	2.10 USD	$500K	conv 62Cluster	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	OtherD (derivative)	-130,180	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	Buy	35,000	16.00 USD	$560K	conv 62ClusterUnusual size	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	Other	131,595	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2026	AwardD (derivative)	53,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2026	Award	35,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 2, 2026	AwardD (derivative)	42,671	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 2, 2026	Award	21,335	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2025	Award	12,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 5, 2025	AwardD (derivative)	19,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 4, 2025	Award	56,623	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 4, 2025	AwardD (derivative)	113,246	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	Gift	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	BuyD (derivative)	561,797	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	BuyD (derivative)	561,797	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 26, 2024	Buy	1,123,595	—	n/a (No price was disclosed in the filing)	conv 90ClusterFirst in 12mo	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 10, 2024	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 31, 2024	Award	49,220	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	May 31, 2024	AwardD (derivative)	98,440	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	388,889	0.90 USD	$350K	conv 57ClusterFirst in 12mo	SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Buy	388,889	0.90 USD	$350K	conv 60ClusterFirst in 12mo	SEC
Taysha Gene Therapies, Inc.Listing on record	Aug 16, 2023	Gift	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 26, 2023	AwardD (derivative)	43,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 7, 2023	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verrica Pharmaceuticals Inc.Listing on record	Jul 5, 2022	Buy	238,095	2.10 USD	$500K	conv 62Cluster	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	OtherD (derivative)	-130,180	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	Buy	35,000	16.00 USD	$560K	conv 62ClusterUnusual size	SEC
Acumen Pharmaceuticals, Inc.Listing on record	Jul 8, 2021	Other	131,595	—	n/a (No price was disclosed in the filing)		SEC